Page last updated: 2024-12-05

4-hydroxyisophthalic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-Hydroxyisophthalic acid (4-HIPA) is a dicarboxylic acid that serves as an important monomer in the synthesis of various high-performance polymers. It exhibits high thermal stability, excellent flame retardancy, and good mechanical properties, making it valuable in applications like flame-retardant polymers, high-temperature resins, and optical fibers. Its synthesis can be achieved through various methods, including oxidation of 4-hydroxytoluene, condensation reactions, and direct carboxylation of aromatic compounds. Research on 4-HIPA focuses on its potential to enhance the properties of polymers, exploring its impact on flame retardancy, mechanical strength, and thermal stability. The study of 4-HIPA is driven by the demand for advanced materials with improved fire safety, durability, and high-temperature performance. Its unique structure and functionality contribute to its potential in various fields, including aerospace, automotive, and electronics.'
```

4-hydroxyisophthalic acid: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID12490
SCHEMBL ID330378
MeSH IDM0126563

Synonyms (54)

Synonym
4-10-00-02091 (beilstein handbook reference)
p87ff77o00 ,
unii-p87ff77o00
nsc2445
nsc-2445
4-hydroxyisophthalic acid
4-hydroxy-1,3-benzenedicarboxylic acid
isophthalic acid, 4-hydroxy-
636-46-4
eupirina
4-hydroxybenzene-1,3-dicarboxylic acid
4-hydroxy-m-phthalic acid
ai3-24050
einecs 211-258-0
4-hipa
1,3-benzenedicarboxylic acid, 4-hydroxy-
nsc 2445
brn 2211981
inchi=1/c8h6o5/c9-6-2-1-4(7(10)11)3-5(6)8(12)13/h1-3,9h,(h,10,11)(h,12,13
H0257
AKOS000121471
A21110
4-hydroxy isophthalic acid
FT-0618715
S10412
4-hydroxyisophthalic acid [mi]
acetylsalicylic acid impurity b [ep impurity]
salicylic acid impurity b [ep impurity]
CS-M1087
SCHEMBL330378
4-hydroxyisophtalic acid
BCEQKAQCUWUNML-UHFFFAOYSA-N
W-203364
4-hydroxyisophthalicacid
AC-28654
C21168
4-hydroxy-1,3-benzenedicarboxylate
4-hydroxyisophthalic acid;
4-hydroxyisophthalate
4-hydroxyisophthalic acid, 95%
mfcd00010391
4-hydroxyisophthalic acid, aldrichcpr
salicylic acid impurity b, european pharmacopoeia (ep) reference standard
BBL103288
STL557098
DTXSID50862332
SY051837
4-hydroxylisophthalic acid
AS-19417
AMY25746
Q27286362
EN300-21599
Z104503646
PD065620
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (24)

TimeframeStudies, This Drug (%)All Drugs %
pre-199018 (75.00)18.7374
1990's1 (4.17)18.2507
2000's0 (0.00)29.6817
2010's3 (12.50)24.3611
2020's2 (8.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 24.30

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index24.30 (24.57)
Research Supply Index3.26 (2.92)
Research Growth Index4.23 (4.65)
Search Engine Demand Index26.67 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (24.30)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other25 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]